Irisin can significantly improve glucose tolerance in obese mice and inhibit hepatic gluconeogenesis and increases glycogen synthesis in T2DM and hepatocytes (Liu, Shi, et al., 2015), which provides the new hope of irisin as the target for the prevention and treatment of T2DM. The gene discussed is FNDC5; the disease is type 2 diabetes mellitus.